Christopher R. Czajka

FDA investigator · also recorded as -. Christopher Czajka

Appears on 37 documents from 2015 to 2025, most often at sites in California. Most often cites insanitary conditions (FDCA 501(a)(2)(A)).

37
Documents on file
5.3
Observations per 483
2015
First seen
2025
Most recent

What they cite most

From 205 observations

Activity by year

2015: 1, 2016: 5, 2017: 1, 2019: 6, 2020: 3, 2021: 3, 2022: 4, 2023: 7, 2024: 4, 2025: 3

Where

California 14 · Washington 10 · Idaho 3 · Japan 3 · Oregon 2 · Colorado 1

Is Christopher R. Czajka coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

37 documents, newest first
FirmOpen
483 SEAGEN INCMay 13, 2025 · Bothell, Washington
483 PureTek CorporationMar 7, 2025 · San Fernando, California
483 LIFETECH RESOURCES LLCMar 3, 2025 · MOORPARK, California
483 AAA Molybdenum Products, Inc.Dec 5, 2024 · Broomfield, Colorado
483 Jubilant HollisterStier LLCJun 6, 2024 · Spokane, Washington
483 Taenaka Kogyo Co., Ltd. 452 OshibaApr 12, 2024 · Mobara, Japan
483 Chugai Pharma Manufacturing Co. Ltd.Apr 2, 2024 · Utsunomiya, Japan

About this profile

What does Christopher R. Czajka inspect?

Christopher R. Czajka appears on 37 documents on file covering 35 sites, most often in California.

What do they cite most often?

FDCA 501(a)(2)(A) (insanitary conditions), followed by 21 CFR 211.100 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Christopher R. Czajka is dated May 13, 2025.